Freshpet, Inc.: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 6, 2024 and accepted by EDGAR at May 6, 2024, 16:08 ET.
Management's discussion and analysis
As filed, 37,402 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion summarizes the significant factors affecting our consolidated operating results, financial condition, liquidity and cash flows as of and for the periods presented below. The following discussion and analysis should be read in conjunction with the accompanying unaudited condensed consolidated financial statements and related notes in Item 1 and with the audited consolidated financial statements and the related notes included in our Annual Report on Form 10-K for the year ended December 31, 2023 (our "Annual Report").
In addition to historical information, this discussion and analysis contains forward-looking statements based on current expectations that involve risks, uncertainties and assumptions, such as our plans, objectives, expectations, and intentions. Our actual results and the timing of events may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in the section entitled "Forward-Looking Statements" in this report and in the section entitled "Risk Factors" in our Annual Report.
Overview
We started Freshpet with a single-minded mission to bring the power of real, fresh food to our dogs and cats. We were inspired by the rapidly growing view among pet owners that their dogs and cats are a part of their family, leading them to demand healthier pet food choices. Since Freshpet's inception in 2006, we have created a comprehensive business model to deliver wholesome pet food that pet parents can trust, and in the process we believe we have become one of the fastest growing pet food companies in North America. Our business model is difficult for others to replicate and we see significant opportunity for future growth by leveraging the unique elements of our business, including our brand, our product know-how, our Freshpet Kitchens, our refrigerated distribution, our Freshpet Fridge and our culture.
Components of our Results of Operations
Net Sales
Our net sales are derived from the sale of pet food products that are sold to retailers through broker and distributor arrangements. Our products are sold to consumers through a fast-growing network of company-owned branded refrigerators, known as Freshpet Fridges, located in our customers’ stores. We continue to roll out Freshpet Fridges at leading retailers across North America and parts of Europe and have installed Freshpet Fridges in approximately 27,097 retail stores as of March 31, 2024. Our products are sold under the Freshpet brand name with ingredients, packaging and labeling customized by class of retail. Sales are recorded net of discounts, returns and promotional allowances.
Our net sales growth is driven by the following key factors:
- Increasing sales velocity from the average Freshpet Fridge due to increasing awareness, trial and adoption of Freshpet products and innovation. Our investments in marketing and advertising help to drive awareness and trial at each point of sale.
- Increasing penetration of Freshpet Fridge locations in major classes of retail, including Grocery, Mass, International, Digital, Pet Specialty, and Club. The impact of new Freshpet Fridge installations on our net sales varies by retail class and depends on numerous factors including store traffic, refrigerator size, placement within the store, and proximity to other stores that carry our products.
- Consumer trends including growing pet ownership, pet humanization and a focus on health and wellness.
- At times we increase our sales price to offset any adverse movement in input costs.
Gross Profit
Our gross profit is net of costs of goods sold, which include the costs of product manufacturing, product ingredients, packaging materials and inbound freight, as well as depreciation and amortization and non-cash share based compensation.
We expect to continue to mitigate any adverse movement in input costs through a combination of cost management and price increases.
Selling, General and Administrative Expenses
Our selling, general and administrative expenses consist of the following:
Outbound freight. We use a third-party logistics provider for outbound freight that ships directly to retailers as well as third-party distributors.
Marketing & advertising. Our marketing and advertising expenses primarily consist of national television media, digital marketing, social media and grass roots marketing to drive brand awareness. These expenses may vary from quarter to quarter depending on the timing of our marketing and advertising campaigns. Our Feed the Growth initiative focuses on growing the business through increased marketing investments.
Freshpet Fridge operating costs. Freshpet Fridge operating costs consist of repair costs and depreciation. The purchase and installation costs for new Freshpet Fridges are capitalized and depreciated over the estimated useful life. All new refrigerators are covered by a manufacturer warranty for three years. We subsequently incur maintenance and freight costs for repairs and refurbishments handled by third-party service providers.
Research & development. Research and development costs consist of expenses to develop and test new products. The costs are expensed as incurred.
Brokerage. We use third-party brokers to assist with monitoring our products at the point-of-sale as well as representing us at headquarters for various customers. These brokers visit our retail customers’ store locations to ensure items are appropriately stocked and maintained.
Share-based compensation. We account for all share-based compensation payments issued to employees, directors and non-employees using a fair value method. Accordingly, share-based compensation expense is measured based on the estimated fair value of the awards on the grant date using the Black-Scholes Merton option-pricing model. We recognize compensation expense for the portion of the award that is ultimately expected to vest over the period during which the recipient renders the required services to us using the straight-line single option method.
Other general & administrative costs. Other general and administrative costs include non-plant personnel salaries and benefits, as well as corporate general & administrative costs.
Income Taxes
We had federal net operating loss (“NOL”) carry forwards of approximately $420.3 million as of December 31, 2023, of which approximately $175.4 million, generated in 2017 and prior, will expire between 2025 and 2037. The NOLs generated from 2018 through 2023, of approximately $244.9 million, will have an indefinite carryforward period but can generally only be used to offset 80% of taxable income in any particular year. We may be subject to certain limitations in our annual utilization of NOL carry forwards to off-set future taxable income pursuant to Section 382 of the Internal Revenue Code, which could result in NOLs expiring unused. At December 31, 2023, we had approximately $312.8 million of state NOLs, which expire between 2024 and 2043, and had $20.7 million of foreign NOLs in the United Kingdom which do not expire. At December 31, 2023, we had a full valuation allowance against our net deferred tax assets as the realization of such assets was not considered more likely than not.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(Dollars in thousands)
| Three Months Ended March 31, 2024 Amount | % of Net Sales | 2023 Amount | % of Net Sales | |
|---|---|---|---|---|
| Net sales | $223,849 | 100% | $167,522 | 100% |
| Cost of goods sold | 135,691 | 61 | 116,762 | 70 |
| Gross profit | 88,158 | 39 | 50,760 | 30 |
| Selling, general and administrative expenses | 79,695 | 36 | 72,271 | 43 |
| Income (loss) from operations | 8,463 | 4 | (21,511) | (13) |
| Interest and other income, net | 3,335 | 1 | 946 | 1 |
| Interest expense | (3,060) | (1) | (3,171) | (0) |
| Gain on equity investment | 9,918 | 4 | - | 0 |
| Income (loss) before income taxes | 18,656 | 8 | (23,736) | (14) |
| Income tax expense | 54 | 0 | 70 | 0 |
| Loss on equity method investment | - | - | 980 | 1 |
| Net income (loss) | $18,602 | 8% | $(24,786) | (15)% |
24
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
Net Sales
The following table sets forth net sales by class of retailer:
(Dollars in thousands)
| Three Months Ended March 31, 2024 Amount | % of Net Sales | 2023 Amount | % of Net Sales | |
|---|---|---|---|---|
| Grocery, Mass, International and Digital | $184,429 | 82% | $140,179 | 84% |
| Pet Specialty and Club | 39,420 | 18% | 27,343 | 16% |
| Net Sales | $223,849 | 100% | $167,522 | 100% |
Net sales increased $56.3 million, or 33.6%, to $223.8 million for the three months ended March 31, 2024 as compared to $167.5 million in the same period in the prior year. The $56.3 million increase in net sales was driven by growth in the Grocery, Mass, International and Digital channel of $44.3 million, with the remaining growth in the Pet Specialty and Club channel. The net sales increase was primarily driven by volume gains of 30.6%.
Gross Profit
Gross profit was $88.2 million, or 39.4% as a percentage of net sales, for the three months ended March 31, 2024, compared to $50.8 million, or 30.3% as a percentage of net sales, in the prior year period. The increase in gross profit as a percentage of net sales was primarily due to improved leverage on plant expenses, reduced quality costs, and lower input cost as a percentage of sales. For the three months ended March 31, 2024, Adjusted Gross Profit was $101.5 million, or 45.3% as a percentage of net sales, compared to $64.4 million, or 38.5% as a percentage of net sales, in the prior year period.
See “—Non-GAAP Financial Measures” for how we define Adjusted Gross Profit, a reconciliation of Adjusted Gross Profit to gross profit, the closest comparable U.S. GAAP measure, certain limitations of Non-GAAP measures and why management has included such Non-GAAP measures.
Selling, General and Administrative Expenses
Selling, general and administrative expenses ("SG&A") were $79.7 million for the three months ended March 31, 2024, compared to $72.3 million in the prior year period. As a percentage of net sales, SG&A decreased to 35.6% for the three months ended March 31, 2024, compared to 43.1% in the prior year period. The decrease of 750 basis points in SG&A as a percentage of net sales was mainly a result of reduced logistics costs and media as a percentage of net sales, in addition to lower share-based compensation.
Adjusted SG&A for the three months ended March 31, 2024, was $70.9 million, or 31.7% as a percentage of net sales, compared to $61.5 million, or 36.7% as a percentage of net sales, in the prior year period.
See “—Non-GAAP Financial Measures” for how we define Adjusted SG&A, a reconciliation of Adjusted SG&A to SG&A, the closest comparable U.S. GAAP measure, certain limitations of Non-GAAP measures and why management has included such Non-GAAP measures.
Income (Loss) from Operations
As a result of the factors discussed above, income from operations increased by $30.0 million to an income from operations of $8.5 million for the three months ended March 31, 2024 as compared to a loss from operations of $21.5 million for the same period in the prior year.
Interest and Other Income, net
The Company recorded interest and other income, net of $3.3 million for the three months ended March 31, 2024 as a result of interest income generated from cash and cash equivalents as compared to $0.9 million for the three months ended March 31, 2023.
Interest Expense
Interest expense decreased $0.1 million to interest expense of $3.1 million for the three months ended March 31, 2024 as compared to interest expense of $3.2 million for the same period in the prior year. The decrease was primarily driven by the termination of our Credit Agreement in the prior year period resulting in the write-off of unamortized fees of $2.5 million, which were recorded to interest expense, partially offset by a $1.8 million increase (net of the $1.0 million of capitalized interest) as a result of interest incurred on our Convertible Notes as compared to interest incurred on the Credit Agreement that existed in the prior year period, as well as a $0.6 million increase related to the interest on our finance lease liability.
Gain on Equity Investment
The $9.9 million gain on equity investment for the three months ended March 31, 2024, resulted from the change in fair value of the Company's equity interest in a privately held company, as discussed in Note 1 of our (unaudited) condensed consolidated financial statements.
Net Income (Loss)
Net income increased $43.4 million to a net income of $18.6 million for the three months ended March 31, 2024, as compared to a net loss of $24.8 million for the same period in the prior year due to contribution from higher sales, improved gross margin, reduced logistics costs as a percentage of net sales, and gain on equity investment, partially offset by increased SG&A expenses including increased media spend of $6.1 million.
Adjusted EBITDA
Adjusted EBITDA was $30.6 million for the three months ended March 31, 2024, compared to $3.0 million in the prior year period. The increase in Adjusted EBITDA was a result of increased Adjusted Gross Profit partially offset by higher Adjusted SG&A expenses.
See "—Non-GAAP Financial Measures" for how we define Adjusted EBITDA, a reconciliation of Adjusted EBITDA to net income (loss) the closest comparable U.S. GAAP measure, certain limitations of Non-GAAP measures and why management has included such Non-GAAP measures; see the section entitled "Forward-Looking Statements" in this report and the section entitled "Risk Factors" in our Annual Report for factors that could cause our results to differ, in some cases materially.
Non-GAAP Financial Measures
Freshpet uses the following non-GAAP financial measures in its financial communications. These non-GAAP financial measures should be considered as supplements to the U.S. GAAP reported measures, should not be considered replacements for, or superior to, the U.S. GAAP measures and may not be comparable to similarly named measures used by other companies.
- Adjusted Gross Profit
- Adjusted Gross Profit as a percentage of net sales (Adjusted Gross Margin)
- Adjusted SG&A expenses
- Adjusted SG&A expenses as a percentage of net sales
- EBITDA
- Adjusted EBITDA
- Adjusted EBITDA as a percentage of net sales (Adjusted EBITDA Margin)
Such financial measures are not financial measures prepared in accordance with U.S. GAAP. We define Adjusted Gross Profit as Gross Profit before depreciation expense, non-cash share-based compensation, and loss on disposal of manufacturing equipment. We define Adjusted SG&A as SG&A expenses before depreciation and amortization expense, non-cash share-based compensation, implementation and other costs associated with the implementation of an ERP system, fees related to the Capped Call Transactions, loss on disposal of equipment, and advisory fees related to activism engagement. EBITDA represents net income (loss) plus interest expense net of interest income, income tax expense and depreciation and amortization. Adjusted EBITDA represents EBITDA plus loss on equity method investment, gain on equity investment, non-cash share-based compensation, implementation and other costs associated with the implementation of an ERP system, loss on disposal of property, plant and equipment, fees related to the Capped Call Transactions, and advisory fees related to activism engagement.
We believe that each of these non-GAAP financial measures provide additional metrics to evaluate our operations and, when considered with both our U.S. GAAP results and the reconciliation to the closest comparable U.S. GAAP measures, provides a more complete understanding of our business than could be obtained absent this disclosure. We use the non-GAAP financial measures, together with U.S. GAAP financial measures, such as net sales, gross profit margins and cash flow from operations, to assess our historical and prospective operating performance, to provide meaningful comparisons of operating performance across periods, to enhance our understanding of our operating performance and to compare our performance to that of our peers and competitors.
Adjusted EBITDA is also an important component of internal budgeting and setting management compensation.
The non-GAAP financial measures are presented here because we believe they are useful to investors in assessing the operating performance of our business without the effect of non-cash items, and other items as detailed below. The non-GAAP financial measures should not be considered in isolation or as alternatives to net income (loss), income (loss) from operations or any other measure of financial performance calculated and prescribed in accordance with U.S. GAAP. Neither EBITDA nor Adjusted EBITDA should be considered a measure of discretionary cash available to us to invest in the growth of our business. Our non-GAAP financial measures may not be comparable to similarly titled measures in other organizations because other organizations may not calculate non-GAAP financial measures in the same manner as we do.
Our presentation of the non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by the expenses that are excluded from that term or by unusual or non-recurring items. We recognize that the non-GAAP financial measures have limitations as analytical financial measures. For example, the non-GAAP financial measures do not reflect:
- our capital expenditures or future requirements for capital expenditures;
- the interest expense, or the cash requirements necessary to service interest expense or principal payments, associated with indebtedness;
- depreciation and amortization, which are non-cash charges, although the assets being depreciated and amortized will likely have to be replaced in the future, nor any cash requirements for such replacements; and
- changes in our cash requirements for our working capital needs.
Additionally, Adjusted EBITDA excludes (i) non-cash share-based compensation expense, which is and will remain a key element of our overall long-term incentive compensation package, and (ii) certain costs essential to our sales growth and strategy. Adjusted EBITDA also excludes certain cash charges resulting from matters we consider not to be indicative of our ongoing operations. Other companies in our industry may calculate the non-GAAP financial measures differently than we do, limiting their usefulness as comparative measures.
The following table provides a reconciliation of EBITDA and Adjusted EBITDA to net income (loss), the most directly comparable financial measure presented in accordance with U.S. GAAP:
(Dollars in thousands)
| Three Months Ended March 31, 2024 | 2023 | |
|---|---|---|
| Net income (loss) | $18,602 | $(24,786) |
| Depreciation and amortization | 15,745 | 14,492 |
| Interest income, net of interest expense | (275) | 2,225 |
| Income tax expense | 54 | 70 |
| EBITDA | $34,126 | $(7,999) |
| Loss on equity method investment | — | 980 |
| Gain on equity investment | (9,918) | — |
| Loss on disposal of property, plant and equipment | 150 | 268 |
| Non-cash share-based compensation (a) | 6,221 | 8,415 |
| Enterprise Resource Planning (b) | — | 801 |
| Capped Call Transactions fees (c) | — | 113 |
| Activism engagement (d) | — | 389 |
| Adjusted EBITDA | $30,579 | $2,967 |
| Adjusted EBITDA as a % of Net Sales | 13.7% | 1.8% |
(a) Includes true-ups, if required, to share-based compensation expense compared to prior periods. We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA and/or Net Sales targets as a condition of vesting. At each reporting period, we reassess the probability of achieving the performance criteria and the performance period required to meet those targets. When such performance conditions are deemed to be improbable of achievement, the compensation cost previously recorded is reversed.
(b) Represents costs associated with the implementation of an ERP system.
(c) Represents fees associated with the Capped Call Transactions.
(d) Represents advisory fees related to activism engagement.
28
The following table provides a reconciliation of Adjusted Gross Profit to Gross profit, the most directly comparable financial measure presented in accordance with U.S. GAAP:
(Dollars in thousands)
| Three Months Ended March 31, 2024 | 2023 | |
|---|---|---|
| Gross profit | $88,158 | $50,760 |
| Depreciation expense | 10,675 | 10,721 |
| Non-cash share-based compensation (a) | 2,622 | 2,956 |
| Loss on disposal of manufacturing equipment | 21 | — |
| Adjusted Gross Profit | $101,476 | $64,437 |
| Adjusted Gross Profit as a % of Net Sales | 45.3% | 38.5% |
(a) Includes true-ups, if required, to share-based compensation expense compared to prior periods. We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA and/or Net Sales targets as a condition of vesting. At each reporting period, we reassess the probability of achieving the performance criteria and the performance period required to meet those targets. When such performance conditions are deemed to be improbable of achievement, the compensation cost previously recorded is reversed.
The following table provides a reconciliation of Adjusted SG&A Expenses to SG&A expenses, the most directly comparable financial measure presented in accordance with U.S. GAAP:
(Dollars in thousands)
| Three Months Ended March 31, 2024 | 2023 | |
|---|---|---|
| SG&A expenses | $79,695 | $72,271 |
| Depreciation and amortization expense | 5,070 | 3,771 |
| Non-cash share-based compensation (a) | 3,600 | 5,459 |
| Loss on disposal of equipment | 129 | 268 |
| Enterprise Resource Planning (b) | — | 801 |
| Capped Call Transactions fees (c) | — | 113 |
| Activism engagement (d) | — | 389 |
| Adjusted SG&A Expenses | $70,896 | $61,470 |
| Adjusted SG&A Expenses as a % of Net Sales | 31.7% | 36.7% |
(a) Includes true-ups, if required, to share-based compensation expense compared to prior periods. We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA and/or Net Sales targets as a condition of vesting. At each reporting period, we reassess the probability of achieving the performance criteria and the performance period required to meet those targets. When such performance conditions are deemed to be improbable of achievement, the compensation cost previously recorded is reversed.
(b) Represents costs associated with the implementation of an ERP system.
(c) Represents fees associated with the Capped Call Transactions.
(d) Represents advisory fees related to activism engagement.
29
Liquidity and Capital Resources
To meet our capital needs, we issued approximately $402.5 million in convertible notes in March 2023 (the “Convertible Notes”), used $66.2 million of the proceeds to enter into capped call transactions, and used $11.0 million of the proceeds on debt issuance related costs. Further, on March 13, 2023, in connection with the proposed offering of the Convertible Notes, the Company, notified City National Bank, of Freshpet's intent to terminate the Credit Agreement, and such termination became effective as of March 15, 2023 (the "Termination Date"). The Company had no borrowings outstanding under the Credit Agreement as of the date of the Termination Date.
We expect to make future capital expenditures in connection with the completion of our planned development of Freshpet Kitchens Ennis Phase 2 and 3. During the three months ended March 31, 2024, we spent approximately $46.5 million of capital to meet our capacity needs as well as recurring capital expenditures. We expect to spend an additional $163.5 million in the remainder of fiscal 2024.
We expect to rely on our current and future cash flow from operations, may issue additional debt, and/or raise capital through our access to capital markets, if appropriate. Our ability to obtain additional funding will be subject to various factors, including general economic and market conditions, our operating performance, the market’s perception of our growth potential, lender sentiment and our ability to incur additional debt in compliance with other contractual restrictions.
Our ability to make future minimum interest payments on the Convertible Notes, to refinance any indebtedness and to fund any necessary expenditures for our growth will depend on our ability to generate cash in the future. If our business does not achieve the levels of profitability or generate the amount of cash that we anticipate or if we expand faster than anticipated, we may need to seek additional debt or equity financing to operate and expand our business. Future third-party financing may not be available on favorable terms or at all.
Our primary cash needs, in addition to our plant expansions, are for purchasing ingredients, operating expenses, marketing expenses and capital expenditures to procure Freshpet Fridges. We believe that cash and cash equivalents, expected cash flow from operations, amounts previously raised through the issuance of the Convertible Notes and our ability to access the capital markets, if appropriate, are adequate to fund our debt requirements, operating and finance lease obligations, capital expenditures and working capital obligations for the foreseeable future. We believe our sources of liquidity and capital will be sufficient to finance our continued operations, growth strategy and additional expenses we expect to incur for at least the next twelve months. However, our ability to continue to meet these requirements and obligations will depend on, among other things, our ability to achieve anticipated levels of revenue and cash flow from operations and our ability to manage costs and working capital successfully. Additionally, our cash flow generation ability is subject to general economic factors, including but not limited to increasing interest rates and inflation, financial, competitive, legislative and regulatory factors and other factors that are beyond our control. We cannot assure you that our business will generate cash flow from operations in an amount sufficient to enable us to fund our liquidity needs. Expanding certain of our Freshpet Kitchens primarily comprises our material future cash requirement. However, our capital requirements, including our cash requirements, may vary materially from those currently planned if, for example, our revenues do not reach expected levels, or we have to incur unforeseen capital expenditures and make investments to maintain our competitive position. If this is the case, we may seek alternative financing, such as selling additional debt or equity securities, and we cannot assure you that we will be able to do so on favorable terms, if at all. Moreover, if we issue new debt securities, the debt holders would have rights senior to common stockholders to make claims on our assets, and the terms of any debt could restrict our operations, including our ability to pay dividends on our common stock. If we issue additional equity or if the Convertible Notes are converted to common shares, existing stockholders may experience dilution, and such new securities could have rights senior to those of our common stock. These factors may make the timing, amount, terms and conditions of additional financing unattractive. Our inability to raise capital could impede our growth or otherwise require us to forego growth opportunities and could materially adversely affect our business, financial condition and results of operations.
The following table sets forth, for the periods indicated, our working capital:
(Dollars in thousands)
| March 31, 2024 | December 31, 2023 | |
|---|---|---|
| Cash and cash equivalents | $257,894 | $296,871 |
| Accounts receivable, net of allowance for doubtful accounts | 68,507 | 56,754 |
| Inventories, net | 71,865 | 63,238 |
| Prepaid expenses | 5,757 | 7,615 |
| Other current assets | 2,935 | 2,841 |
| Accounts payable | (46,591) | (36,096) |
| Accrued expenses | (32,193) | (49,816) |
| Current operating lease liabilities | (1,174) | (1,312) |
| Current finance lease liabilities | (1,988) | (1,998) |
| Total Working Capital | $325,012 | $338,097 |
Working capital consists of current assets net of current liabilities. Working capital decreased $13.1 million to $325.0 million as of March 31, 2024 compared with working capital of $338.1 million as of December 31, 2023. The decrease was primarily a result of a decrease of $39.0 million in cash and cash equivalents, a decrease in prepaid expenses of $1.9 million, and an increase in accounts payable of $10.5 million as a result of timing and capital expenditures of approximately $16.1 million related to our capital expansion plan. The decrease was partially offset by an increase in accounts receivable of $11.8 million, an increase in inventories, net of $8.6 million, and a decrease in accrued expenses of $17.6 million due to timing and capital expenditures of approximately $1.3 million related to our capital expansion plan.
We normally carry three to four weeks of finished goods inventory and less than 30 days of accounts receivable.
For the quarter ended March 31, 2024, our capital resources consisted primarily of $257.9 million of cash and cash equivalents on hand.
For the year ended December 31, 2023, our capital resources consisted primarily of $296.9 million of cash and cash equivalents on hand.
We expect to fund our ongoing operations and obligations with cash and cash equivalents, and cash flow from operations.
The following table sets forth, for the periods indicated, our beginning balance of cash, net cash flows used in operating, investing and provided by financing activities and our ending balance of cash:
(Dollars in thousands)
| Three Months Ended March 31, 2024 | 2023 | |
|---|---|---|
| Cash at the beginning of period | $296,871 | $132,735 |
| Net cash provided by (used in) operating activities | 5,406 | (13,740) |
| Net cash used in investing activities | (46,473) | (107,365) |
| Net cash provided by financing activities | 2,090 | 325,513 |
| Cash at the end of period | $257,894 | $337,143 |
Net Cash Provided by (Used In) Operating Activities
Cash provided by (used in) operating activities consists primarily of net income (loss) adjusted for certain non-cash items (i.e., provision for loss (gains) on receivable, loss on disposal of property, plant and equipment, share-based compensation, change in reserve for inventory obsolescence, depreciation and amortization, write-off and amortization of deferred financing costs and loan discount, change in operating lease right of use asset, loss on equity method investment, and gain on equity investment).
Net cash provided by operating activities of $5.4 million for the three months ended March 31, 2024, was primarily attributed to:
- $32.6 million of net income, adjusted for reconciling non-cash items, which excludes $14.0 million of non-cash items related to $15.9 million of depreciation and amortization, $6.2 million of share-based compensation including amortization of warrants, $0.7 million of reserve for inventory obsolescence, $0.5 million of write-off and amortization of deferred financing costs and loan discount, $0.4 million of change in operating lease right of use asset, and $0.2 million of loss on disposal of property, plant and equipment, partially offset by $9.9 million of gain on equity investment.
This was partially offset by:
- $27.2 million decrease due to changes in operating assets and liabilities. The decrease was primarily due to the change in accrued expenses, accounts receivable, inventories, other assets, and operating lease liability, primarily offset by the change in accounts payable and prepaid expenses and other current assets.
Net cash used in operating activities of $13.7 million for the three months ended March 31, 2023, was primarily attributed to:
- $2.2 million of net income, adjusted for reconciling non-cash items, which excludes $27.0 million non-cash items related to $14.5 million of depreciation and amortization, $8.4 million of share-based compensation including amortization of warrants, $2.5 million of write-off and amortization of deferred financing costs and loan discount, $1.0 million of loss on equity method investment, $0.4 million of change in operating lease right of use asset, and $0.3 million of loss on disposal of property, plant and equipment.
This was offset by:
- $15.9 million decrease due to changes in operating assets and liabilities. The decrease is primarily due to the change in inventories, accounts payable, other assets, and accrued expenses, primarily offset by the change in accounts receivable, and prepaid expenses and other current assets.
Net Cash Used in Investing Activities
Net cash used in investing activities of $46.5 million for the three months ended March 31, 2024, was primarily attributed to:
- $46.5 million of capital expenditures related to Freshpet Kitchens, plant recurring capital expenditures, expenditures relating to investment in fridges, and other capital spend.
Net cash used in investing activities of $107.4 million for the three months ended March 31, 2023, was primarily attributed to:
- $58.0 million of capital expenditures related to Freshpet Kitchens, plant recurring capital expenditures, expenditures relating to investment in fridges, and other capital spend.
- $49.3 million purchase of short-term investments.
Net Cash Provided by Financing Activities
Net cash provided by financing activities of $2.1 million for the three months ended March 31, 2024, was primarily attributed to:
- $2.8 million cash proceeds from the exercise of stock options.
This was partially offset by:
- $0.2 million for tax withholdings related to net share settlements of restricted stock units.
- $0.5 million for principal payments under finance lease obligations.
Net cash provided by financing activities of $325.5 million for the three months ended March 31, 2023, was primarily attributed to:
- $393.5 million net proceeds from Convertible Notes.
- $0.8 million cash proceeds from the exercise of stock options.
This was partially offset by:
- $66.2 million for the purchase of capped call options.
- $2.0 million for debt issuance costs.
- $0.6 million for tax withholdings related to net share settlements of restricted stock units.
33
Indebtedness
For a discussion of our material indebtedness, see Notes 5 and 6 to our (unaudited) condensed consolidated financial statements included in this report.
Contractual Obligations
There were no material changes to our commitments under contractual obligations, as disclosed in our Annual Report, except as noted in Note 8 and 13 of our (unaudited) condensed consolidated financial statements.
Critical Accounting Estimates
Our management’s discussion and analysis of financial condition and results of operations is based on our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States or ("U.S. GAAP"). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the revenue and expenses incurred during the reported periods. On an ongoing basis, we evaluate our estimates and judgments, including those related to accrued expenses and share-based compensation. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not apparent from other sources. Changes in estimates are reflected in reported results for the period in which they become known. Actual results may differ from these estimates under different assumptions or conditions.
There have been no material changes to our critical accounting estimates as compared to the critical accounting policies and estimates described in our Annual Report.
Recent Accounting Pronouncements
Recently Issued Accounting Pronouncements:
See Note 1 of our (unaudited) condensed consolidated financial statements for additional information.
Standards Effective in Future Years:
We consider the applicability and impact of all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB). ASUs not listed herein were assessed and determined to be either not applicable or are expected to have minimal impact to our consolidated financial statements.
Market risk
As filed, 2,106 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Interest Rate Risk
During period of rising interest rates, our cost of borrowing could increase, the fair value of our investments could be affected, and it could constrain the purchasing power of our customers.
Commodity Price and Inflation Risk
We purchase certain products and services that are affected by commodity prices and are, therefore, subject to price volatility caused by weather, market conditions, and other factors which are not considered predictable or within our control. In many cases, we believe we will be able to address material commodity cost increases by either increasing prices or reducing operating expenses. However, increases in commodity prices, without adjustments to pricing or reduction to operating expenses, could increase our operating costs as a percentage of our net sales.
Foreign Exchange Rates
Fluctuations in the currencies of countries where the Company operates outside the U.S. may impact our financial results. The Company is exposed to movements in the British pound sterling and Euro. The Statements of Financial Position of non-U.S. business units are translated into U.S. dollars using period-end exchange rates for assets and liabilities and weighted-average exchange rates for revenues and expenses. The percentage of our consolidated revenue for the three months ended March 31, 2024 recognized in Europe was approximately 1%.
The Company may, from time to time, enter into forward exchange contracts to reduce the Company’s exposure to foreign currency fluctuations of certain assets and liabilities denominated in foreign currencies. Historically, the foreign currency forward contracts have not been designated as hedges and, accordingly, any changes in their fair value are recognized on the Consolidated Statements of Operations and Comprehensive Income (Loss) in Interest and Other Income, net, and carried at their fair value in the Consolidated Balance Sheet with gains reported in prepaid expenses and other current assets and losses reported in accrued expenses. As of March 31, 2024, there were no forward contracts outstanding.
Controls and procedures
As filed, 2,918 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of such date our disclosure controls and procedures were effective.
Changes in Internal Control
There were no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the period covered by this Quarterly Report on Form 10-Q that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitations on Effectiveness of Controls and Procedures
Our management, including our Chief Executive Officer and Chief Financial Officer, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
Risk factors
As filed, 321 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to the risk factors previously reported under Part I, Item 1A. "Risk Factors" in our Annual Report. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may materially affect our business, financial condition and/or operating results.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $223.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $135.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-01-01 to 2024-03-31 | $88.2m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2024-01-01 to 2024-03-31 | $79.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-01-01 to 2024-03-31 | $8.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-01-01 to 2024-03-31 | $3.1m | us-gaap:InterestExpense |
| Income tax | 3 months2024-01-01 to 2024-03-31 | $54.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | $18.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | $0.37 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | $0.38 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 50,049,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-01-01 to 2024-03-31 | $5.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-01-01 to 2024-03-31 | $46.5m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2024-03-31 | $257.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $407.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $1.48bn | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $81.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $502.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-03-31 | $977.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-24-014824. Last ingested by Listed: Nov 4, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.